rs1004191319
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_002691.4(POLD1):c.1403A>G(p.Lys468Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000125 in 1,601,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002691.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.1403A>G | p.Lys468Arg | missense_variant | Exon 12 of 27 | ENST00000440232.7 | NP_002682.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000178 AC: 4AN: 224712Hom.: 0 AF XY: 0.0000165 AC XY: 2AN XY: 121542
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1449258Hom.: 0 Cov.: 36 AF XY: 0.0000139 AC XY: 10AN XY: 719936
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
not provided Uncertain:2
The POLD1 c.1403A>G (p.Lys468Arg) variant has been reported in the published literature in an unaffected individual who did not have a personal or family history of colorectal cancer (PMID: 26344056 (2015)). The frequency of this variant in the general population, 0.000018 (4/224712 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Absent from cases but observed in healthy controls without personal or family history of colorectal cancer (PMID: 26344056); This variant is associated with the following publications: (PMID: 26344056, 20951805) -
Colorectal cancer, susceptibility to, 10 Uncertain:2
- -
This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 468 of the POLD1 protein (p.Lys468Arg). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 408065). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POLD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:2
- -
The p.K468R variant (also known as c.1403A>G), located in coding exon 11 of the POLD1 gene, results from an A to G substitution at nucleotide position 1403. The lysine at codon 468 is replaced by arginine, an amino acid with highly similar properties. This alteration has been reported in at least one of 1508 control individuals who denied a personal or family history of colorectal cancer (Arora S et al. Gastroenterology, 2015 Dec;149:1872-1883.e9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Uncertain:1
Variant summary: POLD1 c.1403A>G (p.Lys468Arg) results in a conservative amino acid change located in the DNA polymerase family B, exonuclease domain (IPR006133) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.8e-05 in 224712 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1403A>G has been reported in the literature in at least one control individual not affected with colorectal cancer (e.g. Arora_2015). This report does not provide unequivocal conclusions about association of the variant with Mandibular Hypoplasia, Deafness, Progeroid Features, And Lipodystrophy Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 26344056). ClinVar contains an entry for this variant (Variation ID: 408065). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Colorectal cancer, susceptibility to, 10;C3715192:Mandibular hypoplasia-deafness-progeroid syndrome;C5935622:Immunodeficiency 120 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at